SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

Twist Bioscience (NASDAQ:TWST) is gearing up to announce its quarterly earnings on Monday, 2025-05-05. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Offers synthetic DNA products, including genes, sample prep tools, antibody libraries, and DNA-based digital data storage solutions. Generates revenue primarily through the sale of synthetic DNA and ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

Twist Bioscience (TWST) stock has decreased by 10.1% in one day. The recent downturn signifies renewed worries regarding wider-than-anticipated losses and ambiguous profitability guidance, but ...

On Monday, Twist Bioscience Corporation (NASDAQ:TWST) reported a fourth-quarter loss per share of 59 cents, beating the consensus loss of 70 cents. Twist Bioscience reported fourth-quarter sales of ...

Twist Bioscience (TWST) stock has attracted fresh attention after a recent move that left shares around $80.79, inviting investors to reassess the company’s synthetic DNA business and current ...

Twist Bioscience (NASDAQ:TWST), a synthetic DNA manufacturer serving healthcare, research, and industrial sectors, reported its third quarter fiscal 2025 results on August 4, 2025. The most notable ...

Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its “Osterweis Opportunity Fund”. A copy of the letter can be downloaded here. The fund returned ...

Twist Bioscience Corporation (NASDAQ: TWST) on Monday posted better-than-expected sales for the first quarter. The company posted first-quarter loss of 50 cents per share, in line with the Wall Street ...

Twist is a biotech company that makes synthetic biology and next-generation sequencing tools to help drug companies find novel therapies for treatments. The company reported third-quarter revenue of ...